•
China-based Shanghai Haohai Biological Technology Co. Ltd (HKG: 6826), a leading biomaterial firm focused on ophthalmology, medical aesthetics, wound care, orthopedics, and anti-adhesion and hemostasis, has announced the acquisition of a 20% stake in compatriot firm Shenzhen New Industries Material of Ophthalmology Co., Ltd (SZNIMO) for a consideration of RMB…